Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AbbVie Pays $60m To Option Alpine’s Lupus Candidate

Jun 18 2020

• By Joseph Haas

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.

Related Content

Immune-Focused Discovery Firm Alpine Goes Public With Nivalis Merger

Apr 19 2017

AbbVie Presents Optimistic Take For 2020, Expects Quick Recovery For Botox Aesthetic

May 01 2020

Deal Watch: Ireland's Amryt Acquires Aegerion

May 21 2019

Related Companies

Alpine Immune Sciences Inc.

AbbVie Inc.

Nivalis Therapeutics, Inc.

Bristol Myers Squibb Company

Amgen, Inc.

Adaptimmune Therapeutics plc

Additional Topics

Deals Business Strategies Commercial Immune Disorders BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.